Sponsor pipeline

Medicine Invention Design, Inc clinical trial pipeline

Get alerts when Medicine Invention Design, Inc's trials change

1 active trials 0 recruiting 1 Phase 3 2 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2/3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2/3
NCT05987956 Pharmacogenomics IND SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Active, Not Recruiting 2026-10-08

Disease areas by active trials

Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1)

Get alerts when Medicine Invention Design, Inc's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free